Vivos (RDGL) Common Equity (2010 - 2026)
Vivos' (RDGL) quarterly Common Equity came in at $950.0 million in Q2 2026, up 35359.7% year-over-year from N/an in Q2 2025, and little changed quarter-over-quarter from $950.0 million in Q4 2025.
Analysis
Vivos (RDGL) Common Equity (2010 - 2026) Analysis & Trends
Vivos has disclosed Common Equity across 17 years of filings, most recently posting $950.0 million for Q2 2026.
- In Q2 2026, Common Equity rose 35359.7% year-over-year to $950.0 million; the TTM figure through Jun 2026 stood at $950.0 million (up 35359.7% YoY), while the FY2025 annual figure was $950.0 million, up 44142.7% from the prior year.
- Common Equity came in at $950.0 million for Q2 2026 at Vivos, roughly flat from $950.0 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $950.0 million in Q4 2025 to a low of $893020.0 in Q2 2022.
- Average Common Equity over 5 years is $113.3 million, with a median of $1.7 million recorded in 2022.
- Year-over-year, Common Equity slumped 45.06% in 2022 and soared 44142.7% in 2025.
- Over 5 years, Common Equity stood at $1.7 million in 2022, then retreated by 17.82% to $1.4 million in 2023, then soared by 57.29% to $2.1 million in 2024, then soared by 44142.7% to $950.0 million in 2025, then changed by 0.0% to $950.0 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $950.0 million in Q2 2026, $950.0 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 18.30 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 50.85 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 23.99 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 25.17 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 10.72 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 21.60 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.62 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | 950.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 950.00 Mn |
| Dec 31, 2025 | 950.00 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 893,020.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Sep 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 1.63 Mn |